Skip to main content

Advertisement

Log in

Optical coherence tomography-guided selective focal laser photocoagulation: a novel laser protocol for diabetic macular edema

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To compare the anatomic and functional results between optical coherence tomography (OCT)-guided selective focal laser photocoagulation (OCT–laser) and conventional modified Early Treatment Diabetic Retinopathy Study (mETDRS) laser treatment for diabetic macular edema (DME).

Methods

We analyzed treatment outcomes in 47 consecutive eyes treated with OCT–laser compared to 31 matched eyes treated with mETDRS. In the OCT–laser group, we identified ‘significant actively-leaking microaneurysms on OCT’ (SALMO) which are responsible for edema in OCT B-scan images, and thoroughly ablated them with photocoagulation. Best-corrected visual acuity (BCVA) and retinal thickness by OCT were compared at baseline and 12 months after treatment between two groups.

Results

OCT–laser treatment resulted in significant improvements in BCVA, central subfield thickness (CST), and maximum retinal thickness (MRT) from baseline at 12 months from the time of therapy (+2.5 letter score, p = 0.04; −45.56 μm in CST, p < 0.001; −91.6 μm in MRT, p < 0.001). The mean number of treated ‘SALMO’ was 5.6 ± 4.0 (range 1–26), while the number of MAs in ‘treatable lesions’ by fluorescein angiography (FA) in the same eye was 16.3 ± 11.8 (range 2–42). There was no difference between OCT–laser and mETDRS groups in changes of these parameters from baseline at 12 months (p = 0.56, p = 0.89, p = 0.43 respectively). Fundus autofluorescence (FAF) and OCT revealed less tissue damage in OCT–laser-treated eyes, compared to eyes treated with mETDRS (p < 0.001).

Conclusions

OCT–laser shows similar anatomic and functional outcomes compared to conventional laser (modified ETDRS), with significantly less retinal damages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Arch Ophthalmol 103:1796–1806

    Article  Google Scholar 

  2. Aiello LP, Edwards AR, Beck RW et al (2010) Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 117:946–953

    Article  PubMed Central  PubMed  Google Scholar 

  3. Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP et al (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064–1077

    Article  Google Scholar 

  4. Blair NP, Shahidi M, Lai WW, Zelkha R (2008) Correlation between microaneurysms and retinal thickness in diabetic macular edema. Retina 28:1097–1103

    Article  PubMed  Google Scholar 

  5. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF et al (2007) Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 125:469–480

    Article  Google Scholar 

  6. Van Dijk HW, Verbraak FD, Kok PHB et al (2013) Variability in photocoagulation treatment of diabetic macular oedema. Acta Ophthalmol 91(8):722–727

    Article  PubMed  Google Scholar 

  7. Massin P, Bandello F, Garweg JG et al (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 33:2399–2405

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Nguyen QD, Brown DM, Marcus DM et al (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119:789–801

    Article  PubMed  Google Scholar 

  9. Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118:615–625

    Article  PubMed  Google Scholar 

  10. Do DV, Nguyen QD, Khwaja AA et al (2013) Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol 131:139–145

    Article  CAS  PubMed  Google Scholar 

  11. Wang H, Chhablani J, Freeman WR et al (2012) Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol 153:861–867

    Article  PubMed Central  PubMed  Google Scholar 

  12. Horii T, Murakami T, Nishijima K et al (2010) Optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Am J Ophthalmol 150:840–848

    Article  PubMed  Google Scholar 

  13. Byeon SH, Chu YK, Hong YT et al (2012) New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography. Retina 32:1087–1099

    Article  PubMed  Google Scholar 

  14. Early Treatment Diabetic Retinopathy Study Research Group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 94:761–774

    Article  Google Scholar 

  15. Shahidi M, Ogura Y, Blair NP et al (1991) Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol 109:1115–1119

    Article  CAS  PubMed  Google Scholar 

  16. Lobo CL, Bernardes RC, Cunha-Vaz JG (2000) Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol 118:1364–1369

    Article  CAS  PubMed  Google Scholar 

  17. Early Treatment Diabetic Retinopathy Study Research Group (1995) Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 113:1144–1155

    Article  Google Scholar 

  18. Lee SN, Chhablani J, Chan CK et al (2013) Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema. Am J Ophthalmol 155:905–912

    Article  PubMed Central  PubMed  Google Scholar 

  19. Tso MO (1982) Pathology of cystoid macular edema. Ophthalmology 89:902–915

    Article  CAS  PubMed  Google Scholar 

  20. Wolter JR (1981) The histopathology of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 216:85–101

    Article  CAS  Google Scholar 

  21. Snodderly DM, Weinhaus RS (1990) Retinal vasculature of the fovea of the squirrel monkey, Saimiri sciureus: three-dimensional architecture, visual screening, and relationships to the neuronal layers. J Comp Neurol 297:145–163

    Article  CAS  PubMed  Google Scholar 

  22. Kozak I, Oster SF, Cortes MA et al (2011) Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology 118:1119–1124

    Article  PubMed  Google Scholar 

  23. Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S (2004) Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina 24:507–511

    Article  PubMed  Google Scholar 

  24. Han DP, Mieler WF, Burton TC (1992) Submacular fibrosis after photocoagulation for diabetic macular edema. Am J Ophthalmol 113:513–521

    Article  CAS  PubMed  Google Scholar 

  25. Nguyen QD, Shah SM, Khwaja AA et al (2010) Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117:2146–2151

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2007865)

Meeting Presentation: Partly presented at the 36th annual meeting of the Macular Society, Feb 2013, Dana Point, CA, USA.

The authors want to thank Hye Sun Lee (Biostatistics Collaboration Unit, Yonsei University College of Medicine) for statistical support.

Conflict of interest

The authors have no proprietary or commercial interest in any materials discussed in this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suk Ho Byeon.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Serial morphological changes on OCT after OCT-guided selective focal laser photocoagulation. Serial regression pattern of ‘significant actively leaking microaneurysms on OCT’ (SALMO) with resolution of adjacent edema after OCT-guided selective focal laser photocoagulation (MPG 4448 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shin, J.Y., Byeon, S.H. & Kwon, O.W. Optical coherence tomography-guided selective focal laser photocoagulation: a novel laser protocol for diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 253, 527–535 (2015). https://doi.org/10.1007/s00417-014-2729-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2729-9

Keywords

Navigation